Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Dr Lal PathLabs acquires remaining CentraPath stake

PRIVATEOct 12, 2026

Acquiring Company

Dr. Lal PathLabs Limited

Acquired Company

CentraPath Labs Private Limited

Dubai EmirateBiotechnologyHealth CareMedicalHealth DiagnosticsBiotechnologyHealth CareMedicalHealth Diagnostics

Description

Dr Lal PathLabs Limited has acquired the remaining 30% equity stake in CentraPath Labs Private Limited through its subsidiary, PathLabs Unifiers Private Limited. The transaction, structured as a cash consideration not exceeding ₹30.3 crore, has been completed immediately. This acquisition consolidates CentraPath as a wholly owned subsidiary of Dr Lal PathLabs. The move is part of a strategy to streamline operations within the group's diagnostics services.

Company Information

Company

Dr. Lal PathLabs Limited

Location

Dubai Emirate, United Arab Emirates

About

Dr. Lal PathLabs Limited is one of India's leading diagnostic chains, specializing in providing top-notch diagnostic services across the country.

Fundz sees it the moment Dr. Lal PathLabs Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Pushkal
Senior decision-maker at this company
••••••••@••••••••

See Pushkal's verified email →

Pushkal
Senior decision-maker at this company
••••••••@••••••••

See Pushkal's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Dr. Lal PathLabs Limited's next move

Learn about Strategic plan

Frequently asked

Who acquired CentraPath Labs Private Limited?

CentraPath Labs Private Limited was acquired by Dr. Lal PathLabs Limited, based in Dubai Emirate. The deal was reported on October 12, 2026. Dr. Lal PathLabs Limited is one of India's leading diagnostic chains, specializing in providing top-notch diagnostic services across the country. Dr. Lal PathLabs Limited is privately held and operates in Biotechnology.

When did Dr. Lal PathLabs Limited acquire CentraPath Labs Private Limited?

Dr. Lal PathLabs Limited's acquisition of CentraPath Labs Private Limited was reported on October 12, 2026. Dr Lal PathLabs Limited has acquired the remaining 30% equity stake in CentraPath Labs Private Limited through its subsidiary, PathLabs Unifiers Private Limited. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does CentraPath Labs Private Limited do?

CentraPath Labs Private Limited is a clinical laboratory that provides a range of diagnostic services. The company is involved in the healthcare sector, focusing on delivering reliable lab results. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.